Longitudinal study on aging and neurodegenerative diseases

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study conducted by the Georgetown University Memory Disorders Program aims to assess the feasibility of various diagnostic tests for Alzheimer's disease, mild cognitive impairment, and other neurodegenerative diseases. Participants will undergo cognitive assessments, lifestyle questionnaires, and provide blood and cerebrospinal fluid specimens for biochemical and genetic testing. The study includes both a main study with a single visit and an optional longitudinal substudy involving annual follow-ups. The findings will not be shared with participants, focusing instead on the research aspect of diagnosis.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Age 45 and older.
* Subjects within the age range of 45-50 years old must have a first degree relative with a neurodegenerative disease.

Exclusion Criteria:

* Individuals under 45 years of age

Where it's running

• Georgetown University Memory Disorders Program
  Washington D.C., District of Columbia, United States Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Observational study on Alzheimer's disease and cognitive health in older adults

  This study is looking for older adults with and without memory problems to help researchers learn more about Alzheimer's disease and improve ways to prevent and treat it.

  Recruiting Vanderbilt University Medical Center · Nashville, Tennessee · NCT05372172

• Gut methane and Parkinson's: measuring if a probiotic helps people with Parkinson's, REM sleep behavior disorder, or cognitive concerns

  This study tests whether a probiotic containing Limosilactobacillus reuteri can help people with Parkinson's disease, those at high risk for PD, and related cognitive issues by potentially improving gut methane levels and overall symptoms.

  Recruiting University of Cambridge · Cambridge, CB2 · NCT07786116

• Blood tests using plasma biomarkers to diagnose and track Alzheimer’s disease

  A large, year-long study in Milan is testing whether blood markers can help diagnose Alzheimer’s and predict how it will progress in people with memory concerns.

  Recruiting IRCCS San Raffaele · Milan, Milano · NCT07717567

• Music for Pain and Dementia: Group Drumming for people with early dementia and their caregivers

  This study tests whether group drumming can reduce pain and change brain activity in people with mild dementia or mild cognitive impairment and in their caregivers.

  Recruiting Yale University · New Haven, Connecticut · NCT07602283

• Fast-track screening to determine eligibility for anti-amyloid treatment using digital cognitive tests and blood biomarkers.

  This project will test whether combining self‑administered digital cognitive tests with blood biomarker results can quickly identify patients referred for memory concerns who may qualify for anti‑amyloid disease‑modifying therapy.

  Recruiting MoCA Clinic and Institute · Greenfield Park, Quebec · NCT07041450

• Ultralow-dose amyloid PET with 18F‑Florbetapir or 18F‑Flutemetamol

  This trial will try using a very small amount of an amyloid PET tracer with a high-sensitivity PET scanner to see if clear brain images can be made for people with Alzheimer’s, mild cognitive impairment, other dementias, and healthy volunteers.

  Recruiting Phase 2 Nuclear Imaging Institute · Englewood, New Jersey · NCT07012993

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.